Quanterix (QTRX) Cash & Current Investments (2017 - 2026)
Quanterix (QTRX) posted Cash & Current Investments of $99.3 million for Q1 2026, down 16.04% on a QoQ basis from $118.2 million in Q4 2025, and down 62.8% year-over-year from $266.9 million in Q1 2025.
Quanterix (QTRX) Cash & Current Investments (2017 - 2026) Analysis & Trends
Quanterix's Cash & Current Investments history runs 10 years deep, the most recent figure standing at $99.3 million for Q1 2026.
- Quarterly Cash & Current Investments fell 62.8% year-over-year to $99.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $99.3 million (down 62.8% YoY) and the FY2025 annual result came in at $118.2 million, down 59.11% from the prior year.
- Cash & Current Investments was $99.3 million for Q1 2026 at Quanterix, down from $118.2 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $374.5 million in Q1 2022 and bottomed at $99.3 million in Q1 2026.
- A 5-year average of $281.7 million and a median of $301.9 million in 2024 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2022 — Cash & Current Investments soared 426.22% — and 2026, when it tumbled 62.8%.
- Quanterix's Cash & Current Investments stood at $338.7 million in 2022, then retreated by 5.14% to $321.3 million in 2023, then decreased by 10.02% to $289.1 million in 2024, then tumbled by 59.11% to $118.2 million in 2025, then fell by 16.04% to $99.3 million in 2026.
- Business Quant data shows QTRX's Cash & Current Investments at $99.3 million in Q1 2026, $118.2 million in Q4 2025, and $134.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.64 Bn | 176.34 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 129.04 Bn | 126.16 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 109.04 Bn | 99.82 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.67 Bn | 45.00 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.34 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 25.48 Bn | 22.36 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Quanterix | 174.76 Mn | 75.50 Mn | 15.57 Mn | 99.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99.27 Mn |
| Dec 31, 2025 | 118.23 Mn |
| Sep 30, 2025 | 134.81 Mn |
| Jun 30, 2025 | 261.17 Mn |
| Mar 31, 2025 | 266.88 Mn |
| Dec 31, 2024 | 289.12 Mn |
| Sep 30, 2024 | 293.52 Mn |
| Jun 30, 2024 | 296.86 Mn |
| Mar 31, 2024 | 301.92 Mn |
| Dec 31, 2023 | 321.32 Mn |
| Sep 30, 2023 | 327.71 Mn |
| Jun 30, 2023 | 329.53 Mn |
| Mar 31, 2023 | 329.35 Mn |
| Dec 31, 2022 | 338.74 Mn |
| Sep 30, 2022 | 343.74 Mn |
| Jun 30, 2022 | 361.55 Mn |
| Mar 31, 2022 | 374.54 Mn |
| Dec 31, 2021 | 64.37 Mn |
| Sep 30, 2021 | 410.75 Mn |
| Jun 30, 2021 | 430.78 Mn |